US Patent Issued to Atai Therapeutics on April 21 for "Dimethyltryptamine analogues as nitric oxide delivery drugs" (American, German Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,525, issued on April 21, was assigned to Atai Therapeutics Inc. (New York).

"Dimethyltryptamine analogues as nitric oxide delivery drugs" was invented by Robert B. Perni (Marlborough, Mass.), Glenn Short (Scituate, Mass.) and Tanweer A. Khan (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds of Formula (I), (II), or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I), (II), or pharmaceutically acceptable salt thereof, and methods of using a compound of Formula (I), (II), or a pharmaceutically acceptable salt thereof."

The patent was ...